Modulation of human neutrophil function by C-reactive protein.
Investigation of the effect of C-reactive protein (CRP), an acute-phase reactant, on the functional capacities of human neutrophils was carried out as the basis for elucidating the biological function of C-reactive protein. An initial stimulation at low concentrations, followed by inhibition of superoxide production, and secretion of vitamin-B12-binding protein in the presence of two stimulants, phorbol myristate acetate and concanavalin A, and of neutrophil chemotaxis with increasing concentration of CRP was observed. Correlation between modulation of cell function, at least at relatively high CRP concentrations (greater than 50 micrograms/ml) and an increase in the intracellular level of cAMP is suggested. CRP was also found to enhance neutrophil phagocytosis of particles not containing phosphorylcholine, the native CRP ligand. The proposed role of CRP in neutrophil function is one of regulation and as a negative feedback for potential cytotoxic neutrophil functions.
D001425:Bacterial Outer Membrane Proteins; D002097:C-Reactive Protein / Q000502:physiology*; D002634:Chemotaxis, Leukocyte; D000242:Cyclic AMP / Q000097:blood; D029968:Escherichia coli Proteins; D006801:Humans; D007700:Kinetics; D026901:Membrane Transport Proteins; D009504:Neutrophils / Q000502:physiology*; D010587:Phagocytosis; D011956:Receptors, Cell Surface / Q000378:metabolism; D018000:Receptors, Peptide; D013481:Superoxides / Q000097:blood
D001425:Bacterial Outer Membrane Proteins; C044592:BtuB protein, E coli; D029968:Escherichia coli Proteins; D026901:Membrane Transport Proteins; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; D013481:Superoxides; D002097:C-Reactive Protein; D000242:Cyclic AMP